Matthew Maurer

Matthew Maurer currently serves as Chief Medical Officer at Myeloid Therapeutics, a position held since November 2023. Prior to this role, Matthew Maurer was the Vice President and Head of Medical Affairs and Clinical Oncology at IDEAYA Biosciences from January 2021 to December 2023. Earlier in the career, Matthew Maurer worked as a Medical Director at Bristol-Myers Squibb from September 2015 to January 2021.